Jul 18, 2017 - Stellar clinical-trial results have pushed AveXis Inc. stock to an all-time high. Is the stock still a buy at recent prices, or should you wait for a pullback?
Apr 13, 2017 - A pipeline of drugs has this biotech poised for further success.
Mar 31, 2017 - Highpower International delivered a bullish Q4 and full-year EPS report today driven by a 40%+ increase in Li-ion battery sales.Full-year net income grew 60% while gross margins increased 2.8% to 21.9
Apr 18, 2017 - Ionis keeps doing what it's good at: developing new drugs and setting up future revenue streams
Jun 27, 2017 - When the M&A bonanza picks up again, Biogen and Bristol-Myers Squibb may be the first to go. Here's why.
Apr 25, 2017 - A strong start for the spinal muscular atrophy drug Spinraza could help Ionis Pharmaceuticals deliver pro forma profit in 2017.
Apr 26, 2017 - Spinraza launch is off to a good start.
Jun 10, 2017 - Amazon has made investors rich over the past 20 years. These three companies could have similar potential.
Sep 20, 2017 - One biotech's phase 3 success means competition for the other.
Apr 27, 2017 - Which of these two pioneering biotech companies are the best place for new money today?